Literature DB >> 9555096

Inhibition of secreted phospholipases A2 by annexin V. Competition for anionic phospholipid interfaces allows an assessment of the relative interfacial affinities of secreted phospholipases A2.

A G Buckland1, D C Wilton.   

Abstract

The ability of annexins, particularly annexin 1 (lipocortin 1), to inhibit phospholipase A2 (PLA2) is well known and a substrate depletion mechanism is now widely accepted as the explanation for most inhibitory studies. In this investigation we have examined the substrate depletion mechanism of annexin V using a variety of phospholipid substrates and secreted PLA2's (sPLA2). The results suggest that the term interfacial competition best describes the inhibitory effect of annexin V although the overall inhibitory process remains one of substrate sequestration by the annexin. We have utilised the competitive nature of the interaction of enzyme and annexin V for a phospholipid interface as a means of quantifying the relative affinity of sPLA2's for anionic phospholipid vesicles. The results highlight the very high affinity of the human non-pancreatic sPLA2 for such vesicles (Kd<<10-(10) M) while the Naja naja venom PLA2 and porcine pancreatic sPLA2 showed lower affinities. Hydrolysis of mixed vesicles containing phosphatidylserine and phosphatidylcholine by the venom and pancreatic enzymes were differentially inhibited by annexin V. This difference must reflect the preference of both annexin V and the pancreatic enzyme for an anionic phospholipid interface. In contrast, the venom enzyme is able to readily hydrolyse phosphatidylcholine domains that would be minimally affected by annexin V. Annexin V was an effective inhibitor of cardiolipin hydrolysis by the pancreatic PLA2, however the inhibition was of a more complex nature than seen with other phospholipids tested. Overall the results highlight the ability of annexin V to inhibit phospholipid hydrolysis by sPLA2's by an interfacial competition (substrate depletion) mechanism. The effectiveness of annexin V as an apparent inhibitor depends on the nature of the enzyme and the phospholipid substrate. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9555096     DOI: 10.1016/s0005-2760(98)00026-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Investigation into the role of phosphatidylserine in modifying the susceptibility of human lymphocytes to secretory phospholipase A(2) using cells deficient in the expression of scramblase.

Authors:  Jennifer Nelson; Lyndee L Francom; Lynn Anderson; Kelly Damm; Ryan Baker; Joseph Chen; Sarah Franklin; Amy Hamaker; Izadora Izidoro; Eric Moss; Mikayla Orton; Evan Stevens; Celestine Yeung; Allan M Judd; John D Bell
Journal:  Biochim Biophys Acta       Date:  2012-01-13

2.  Identification of P-glycoprotein co-fractionating proteins and specific binding partners in rat brain microvessels.

Authors:  Margaret E Tome; Charles P Schaefer; Leigh M Jacobs; Yifeng Zhang; Joseph M Herndon; Fabian O Matty; Thomas P Davis
Journal:  J Neurochem       Date:  2015-04-21       Impact factor: 5.372

3.  Proteomic analysis (GeLC-MS/MS) of ePFT-collected pancreatic fluid in chronic pancreatitis.

Authors:  Joao A Paulo; Vivek Kadiyala; Linda S Lee; Peter A Banks; Darwin L Conwell; Hanno Steen
Journal:  J Proteome Res       Date:  2012-02-07       Impact factor: 4.466

4.  Amyloid precursor protein (APP) mediated regulation of ganglioside homeostasis linking Alzheimer's disease pathology with ganglioside metabolism.

Authors:  Marcus O W Grimm; Eva G Zinser; Sven Grösgen; Benjamin Hundsdörfer; Tatjana L Rothhaar; Verena K Burg; Lars Kaestner; Thomas A Bayer; Peter Lipp; Ulrike Müller; Heike S Grimm; Tobias Hartmann
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

5.  Synovial microparticles from arthritic patients modulate chemokine and cytokine release by synoviocytes.

Authors:  René J Berckmans; Rienk Nieuwland; Maarten C Kraan; Marianne C L Schaap; Desirée Pots; Tom J M Smeets; Augueste Sturk; Paul P Tak
Journal:  Arthritis Res Ther       Date:  2005-03-01       Impact factor: 5.156

6.  Discovery of glycerol phosphate modification on streptococcal rhamnose polysaccharides.

Authors:  Rebecca J Edgar; Vincent P van Hensbergen; Alessandro Ruda; Andrew G Turner; Pan Deng; Yoann Le Breton; Najib M El-Sayed; Ashton T Belew; Kevin S McIver; Alastair G McEwan; Andrew J Morris; Gérard Lambeau; Mark J Walker; Jeffrey S Rush; Konstantin V Korotkov; Göran Widmalm; Nina M van Sorge; Natalia Korotkova
Journal:  Nat Chem Biol       Date:  2019-04-01       Impact factor: 15.040

7.  Annexin-phospholipid interactions. Functional implications.

Authors:  María Antonia Lizarbe; Juan I Barrasa; Nieves Olmo; Francisco Gavilanes; Javier Turnay
Journal:  Int J Mol Sci       Date:  2013-01-28       Impact factor: 5.923

8.  PplD is a de-N-acetylase of the cell wall linkage unit of streptococcal rhamnopolysaccharides.

Authors:  Jeffrey S Rush; Prakash Parajuli; Alessandro Ruda; Jian Li; Amol Arunrao Pohane; Svetlana Zamakhaeva; Mohammad M Rahman; Jennifer C Chang; Artemis Gogos; Cameron W Kenner; Gérard Lambeau; Michael J Federle; Konstantin V Korotkov; Göran Widmalm; Natalia Korotkova
Journal:  Nat Commun       Date:  2022-02-01       Impact factor: 17.694

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.